156 related articles for article (PubMed ID: 22089493)
1. Gene-based therapies for dominantly inherited retinopathies.
Farrar GJ; Millington-Ward S; Chadderton N; Humphries P; Kenna PF
Gene Ther; 2012 Feb; 19(2):137-44. PubMed ID: 22089493
[TBL] [Abstract][Full Text] [Related]
2. A transgenic mouse model for gene therapy of rhodopsin-linked Retinitis Pigmentosa.
O'Reilly M; Millington-Ward S; Palfi A; Chadderton N; Cronin T; McNally N; Humphries MM; Humphries P; Kenna PF; Farrar GJ
Vision Res; 2008 Feb; 48(3):386-91. PubMed ID: 17920651
[TBL] [Abstract][Full Text] [Related]
3. Towards mutation-independent silencing of genes involved in retinal degeneration by RNA interference.
Cashman SM; Binkley EA; Kumar-Singh R
Gene Ther; 2005 Aug; 12(15):1223-8. PubMed ID: 15877050
[TBL] [Abstract][Full Text] [Related]
4. Gene therapeutic approaches for dominant retinopathies.
Farrar GJ; Palfi A; O'Reilly M
Curr Gene Ther; 2010 Oct; 10(5):381-8. PubMed ID: 20712579
[TBL] [Abstract][Full Text] [Related]
5. Ribozyme-based therapeutic approaches for autosomal dominant retinitis pigmentosa.
O'Neill B; Millington-Ward S; O'Reilly M; Tuohy G; Kiang AS; Kenna PF; Humphries P; Farrar GJ
Invest Ophthalmol Vis Sci; 2000 Sep; 41(10):2863-9. PubMed ID: 10967039
[TBL] [Abstract][Full Text] [Related]
6. Toward a gene therapy for dominant disease: validation of an RNA interference-based mutation-independent approach.
Kiang AS; Palfi A; Ader M; Kenna PF; Millington-Ward S; Clark G; Kennan A; O'reilly M; Tam LC; Aherne A; McNally N; Humphries P; Farrar GJ
Mol Ther; 2005 Sep; 12(3):555-61. PubMed ID: 15967729
[TBL] [Abstract][Full Text] [Related]
7. Hereditary degenerative retinopathies: optimism for somatic gene therapy.
Shastry BS
IUBMB Life; 2000 Jun; 49(6):479-84. PubMed ID: 11032240
[TBL] [Abstract][Full Text] [Related]
8. Gene therapy in animal models of autosomal dominant retinitis pigmentosa.
Rossmiller B; Mao H; Lewin AS
Mol Vis; 2012; 18():2479-96. PubMed ID: 23077406
[TBL] [Abstract][Full Text] [Related]
9. Mutation screening of the peropsin gene, a retinal pigment epithelium specific rhodopsin homolog, in patients with retinitis pigmentosa and allied diseases.
Rivolta C; Berson EL; Dryja TP
Mol Vis; 2006 Dec; 12():1511-5. PubMed ID: 17167409
[TBL] [Abstract][Full Text] [Related]
10. Prospects for retinal gene replacement therapy.
Smith AJ; Bainbridge JW; Ali RR
Trends Genet; 2009 Apr; 25(4):156-65. PubMed ID: 19303164
[TBL] [Abstract][Full Text] [Related]
11. On the genetics of retinitis pigmentosa and on mutation-independent approaches to therapeutic intervention.
Farrar GJ; Kenna PF; Humphries P
EMBO J; 2002 Mar; 21(5):857-64. PubMed ID: 11867514
[TBL] [Abstract][Full Text] [Related]
12. Retinopathy mutations in the bZIP protein NRL alter phosphorylation and transcriptional activity.
Kanda A; Friedman JS; Nishiguchi KM; Swaroop A
Hum Mutat; 2007 Jun; 28(6):589-98. PubMed ID: 17335001
[TBL] [Abstract][Full Text] [Related]
13. In vivo dynamics of retinal injury and repair in the rhodopsin mutant dog model of human retinitis pigmentosa.
Cideciyan AV; Jacobson SG; Aleman TS; Gu D; Pearce-Kelling SE; Sumaroka A; Acland GM; Aguirre GD
Proc Natl Acad Sci U S A; 2005 Apr; 102(14):5233-8. PubMed ID: 15784735
[TBL] [Abstract][Full Text] [Related]
14. Mutations within the rhodopsin gene in patients with autosomal dominant retinitis pigmentosa.
Dryja TP; McGee TL; Hahn LB; Cowley GS; Olsson JE; Reichel E; Sandberg MA; Berson EL
N Engl J Med; 1990 Nov; 323(19):1302-7. PubMed ID: 2215617
[TBL] [Abstract][Full Text] [Related]
15. Repair of rhodopsin mRNA by spliceosome-mediated RNA trans-splicing: a new approach for autosomal dominant retinitis pigmentosa.
Berger A; Lorain S; Joséphine C; Desrosiers M; Peccate C; Voit T; Garcia L; Sahel JA; Bemelmans AP
Mol Ther; 2015 May; 23(5):918-930. PubMed ID: 25619725
[TBL] [Abstract][Full Text] [Related]
16. Knockout and Replacement Gene Surgery to Treat Rhodopsin-Mediated Autosomal Dominant Retinitis Pigmentosa.
Sun X; Liang C; Chen Y; Cui T; Han J; Dai M; Zhang Y; Zhou Q; Li W
Hum Gene Ther; 2024 Mar; 35(5-6):151-162. PubMed ID: 38368562
[TBL] [Abstract][Full Text] [Related]
17. Naturally occurring rhodopsin mutation in the dog causes retinal dysfunction and degeneration mimicking human dominant retinitis pigmentosa.
Kijas JW; Cideciyan AV; Aleman TS; Pianta MJ; Pearce-Kelling SE; Miller BJ; Jacobson SG; Aguirre GD; Acland GM
Proc Natl Acad Sci U S A; 2002 Apr; 99(9):6328-33. PubMed ID: 11972042
[TBL] [Abstract][Full Text] [Related]
18. [Identification of Arg-135-Leu mutation in the rhodopsin gene in a family with autosomal dominant retinitis pigmentosa].
Reig C; Antich J; Gean E; Dante Heredia C; Valverde D; Baiget M; Carballo M
Med Clin (Barc); 1996 Feb; 106(6):219-21. PubMed ID: 8667664
[TBL] [Abstract][Full Text] [Related]
19. Rhodopsin mutations in autosomal dominant retinitis pigmentosa.
al-Maghtheh M; Gregory C; Inglehearn C; Hardcastle A; Bhattacharya S
Hum Mutat; 1993; 2(4):249-55. PubMed ID: 8401533
[TBL] [Abstract][Full Text] [Related]
20. Ccdc66 null mutation causes retinal degeneration and dysfunction.
Gerding WM; Schreiber S; Schulte-Middelmann T; de Castro Marques A; Atorf J; Akkad DA; Dekomien G; Kremers J; Dermietzel R; Gal A; Rülicke T; Ibrahim S; Epplen JT; Petrasch-Parwez E
Hum Mol Genet; 2011 Sep; 20(18):3620-31. PubMed ID: 21680557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
